Northwest Biotherapeutics, Inc. Share Price Other OTC
Equities
NWBO
US66737P6007
Biotechnology & Medical Research
Sales 2022 | 1.68M 140M | Sales 2023 | 1.93M 161M | Capitalization | 822M 68.55B |
---|---|---|---|---|---|
Net income 2022 | -105M -8.76B | Net income 2023 | -62M -5.17B | EV / Sales 2022 | 505 x |
Net Debt 2022 | 19.29M 1.61B | Net Debt 2023 | 43.43M 3.62B | EV / Sales 2023 | 448 x |
P/E ratio 2022 |
-7.59
x | P/E ratio 2023 |
-11.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.84% |
Managers | Title | Age | Since |
---|---|---|---|
Linda Powers
CEO | Chief Executive Officer | 68 | 17/07/17 |
Alton Boynton
FOU | Founder | 79 | 18/96/18 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/00/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alton Boynton
FOU | Founder | 79 | 18/96/18 |
Linda Powers
CEO | Chief Executive Officer | 68 | 17/07/17 |
Navid Malik
BRD | Director/Board Member | 55 | 01/12/01 |
1st Jan change | Capi. | |
---|---|---|
+16.45% | 123B | |
+21.96% | 115B | |
+23.73% | 25.85B | |
-20.05% | 20.9B | |
-16.28% | 16.77B | |
-16.52% | 16.52B | |
-44.35% | 15.56B | |
+63.91% | 15.49B | |
+2.52% | 13.45B |